Next Article in Journal / Special Issue
Does the Subject Content of the Pharmacy Degree Course Influence the Community Pharmacist’s Views on Competencies for Practice?
Previous Article in Journal
A European Competence Framework for Industrial Pharmacy Practice in Biotechnology
Article Menu

Export Article

Open AccessArticle
Pharmacy 2015, 3(3), 129-136;

U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study

Division of Clinical, Social and Administrative Sciences, Mylan School of Pharmacy, Duquesne University, 600 Forbes Ave, Pittsburgh, PA 15282, USA
Law Office of Peter P. Cohron, 350 Tartan Dr, Henderson, KY 42420, USA
Author to whom correspondence should be addressed.
Academic Editor: Reem Kayyali
Received: 23 July 2015 / Revised: 18 August 2015 / Accepted: 25 August 2015 / Published: 28 August 2015
(This article belongs to the Special Issue Community Pharmacy)
Full-Text   |   PDF [352 KB, uploaded 28 August 2015]


In October 2014, the Drug Enforcement Administration in the U.S. reclassified hydrocodone combination products (HCPs) from Schedule III to Schedule II, initiating one of the most significant and controversial regulatory changes for opioids in recent national history. The aim of the present study was to determine community pharmacist opinions on the effect of the rescheduling of HCPs on their personal practice. A web-based pilot survey was emailed to a convenience sample through online newsletters of professional pharmacy organizations in Pennsylvania, Kentucky and West Virginia in April/May 2015. A total of 62 surveys were initiated, yielding 56 complete responses. More than 75% of respondents noted increases in their workload as a result of the rescheduling of HCPs. Opinions regarding the intended outcomes of rescheduling were only weakly positive, with only 37.5% of respondents believing it has increased safety and 44.6% of respondents believing it has lessened abuse/diversion. For overall attitudes regarding the rescheduling, respondents were split between positive (26.8%), neutral (26.8%) and negative (46.4%). These initial data suggest that pharmacists have encountered barriers in practice resulting from the rescheduling. Further expanded work is necessary to verify these results from the small sample, and to assess the intended effects of the rescheduling upon the safe and effective use of hydrocodone. View Full-Text
Keywords: opioids; regulation; Drug Enforcement Administration; controlled substance opioids; regulation; Drug Enforcement Administration; controlled substance
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Covvey, J.R.; Pfalzgraf, A.R.; Cohron, P.P. U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study. Pharmacy 2015, 3, 129-136.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top